medigraphic.com
Instituto Nacional de Salud Pública

2006, Number 6

<< Back Next >>

salud publica mex 2006; 48 (6)

Cancer incidence estimates at the national and district levels in Colombia

Piñeros M, Ferlay J, Murillo R

Language: English
References: 28
Page: 455-465
PDF size: 113.49 Kb.


ABSTRACT

Objectives. To estimate national and district cancer incidence for 18 major cancer sites in Colombia. Materials and Methods. National and district incidence was estimated by applying a set of age, sex and site-specific incidence/mortality ratios, obtained from a population-based cancer registry, to national and regional mortality. The work was done in Bogotá (Colombia) and Lyon (France) between May 2003 and August 2004. Results. The annual total number of cases expected (all cancers but skin) was 17 819 in men and 18 772 in women. Among males the most frequent cancers were those of the prostate (45.8 per 100 000), stomach (36.0), and lung (20.0). In females the most frequent were those of the cervix uteri (36.8 per 100 000), breast (30.0), and stomach (20.7). Districts with the lowest death certification coverage yielded the highest incidence rates. Conclusions. In the absence of national population-based cancer registry data, estimates of incidence provide valuable information at national and regional levels. As mortality data are an important source for the estimation, the quality of death certification should be considered as a possible cause of bias.


REFERENCES

  1. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. Cancer registration: Principles and methods. IARC Scientific Publications, No.95. Lyon, France: International Agency for Research on Cancer, 1991.

  2. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer Incidence in Five Continents, Vol. VIII. IARC Scientific Publications No. 155. Lyon: International Agency for Research on Cancer, 2002.

  3. Murillo R, Piñeros M, Hernández G. Atlas de mortalidad por cáncer en Colombia [Colombian Cancer Mortality Atlas]. Instituto Nacional de Cancerología, Instituto Geográfico Agustín Codazzi, Bogotá: Imprenta Nacional, 2004.

  4. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988;(41):184-197.

  5. Jensen OM, Esteve J, Moller H, Renard H. Cancer in the European Community and its member states. Eur J Cancer 1990;(26):1167-1256.

  6. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 1999;80: 827-841.

  7. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997;33(7):1075-1077.

  8. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC CancerBase No. 5. Lyon: IARC Press, 2001.

  9. Departamento Administrativo Nacional de Estadística (Colombia). Bases de datos de mortalidad 1995 – 1999. [Mortality, 1995-1999]. (data base). Bogotá: Done (banco de datos), 2002.

  10. Departamento Administrativo Nacional de Estadística (Colombia). Proyecciones departamentales de población por sexo y edad,1990-2015 [Population projections by district, sex and age, 1990-2015]. Bogotá: Dane (División de ediciones), 1998.

  11. Flórez CE, Medina R. La cobertura de las defunciones en 1993. Informe final para el Ministerio de Salud. [Coverage of mortality reporting in 1993, final report to the Health Ministry]. Bogotá, Colombia: Universidad de Los Andes, 1997.

  12. Loos AH, Bray F, McCarron P, Weiderpass E, Hakama M, Parkin DM. Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality. Eur J Cancer 2004;40(18):2794-2803.

  13. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of Cancer Incidence and Mortality in Europe in 1995. Eur J Cancer 2003;38:99-166.

  14. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Tohoku: University of Medicine, 1960.

  15. Doll R, Payne P, Waterhouse JAH, eds. Cancer Incidence in Five Continents, Vol. I. Geneva: Union Internationale Contre le Cancer, 1966.

  16. Sansón F, Caicedo R, Dorado A. Cáncer incidente en el municipio de Pasto:1999-2001. [Cancer incidence in the district of Pasto:1999-2001]. Alcaldía Municipal de Seguridad Social en Salud, Centro de Estudios en Salud de la Universidad de Nariño. Pasto: Gráficas Ltda, 2002.

  17. Piñeros M, Murillo R. Incidencia de cáncer en Colombia: importancia de las fuentes de información en la obtención de cifras estimativas [Cancer Incidence Estimates in Colombia: Importance of data sources in the obtention of estimation numbers]. Revista Colombiana de Cancerología 2004; 8(1):5-12.

  18. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al (eds). SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975_2003/results_merged/sect_02_all_sites.pdf; based on November 2005 SEER data submission, posted to the SEER web site, 2006.

  19. Piñeros M, Hernandez G, Bray F. Increasing mortality rates of common malignancies in Colombia. Cancer 2004;101(10):2285-2292.

  20. Departamento Administrativo Nacional de Estadística (Colombia). Colombia, proyecciones municipales de población por área,1995-2005 [Population projections by municipalities, sex and age, 1995-2005]. Bogotá: Dane (División de ediciones), 1998.

  21. Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, et al. HPV Study Group HPV Study. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002;87(3):324-333.

  22. Muñoz N, Mendez F, Posso H, Molano M, van den Brule AJ, Ronderos M, et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004;190(12):2077-2087.

  23. Hoffman RM, Stone SN, Hunt WC, Key CR, Gilliland FD. Effects of misattribution in assigning cause of death on prostate cancer mortality rates. Ann Epidemiol 2003;13(6):450-454.

  24. Albertsen PC, Walters S, Hanley JA. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urol 2000; 163(2):519-523.

  25. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003;51(1 Pt 1):3-30.

  26. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Volume IV. Descriptive epidemiology. IARC Sci Publ 1994;(128):1-302.

  27. Departamento Administrativo Nacional de Estadística (Colombia). Manual de principios y procedimientos del Sistema de Registro Civil y Estadísticas Vitales [Guideline of principles and procedures of the System of Civil Registration and vital statistics]. Bogotá:Dane (División de ediciones), 1997.

  28. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide, Version 2.0. IARC CancerBase No. 5. Lyon: IARC Press, 2004.




2020     |     www.medigraphic.com